NanoViricides, Inc. (NNVC)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
| Previous close | 2.1150 |
| Open | 2.1400 |
| Bid | 0.0000 x 1300 |
| Ask | 2.2900 x 1000 |
| Day's range | 2.0700 - 2.2300 |
| 52-week range | 1.0000 - 2.2900 |
| Volume | |
| Avg. volume | 111,914 |
| Market cap | 25.755M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- ACCESSWIRE
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.
© 2024 Yahoo. All rights reserved.